Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Atomo Diagnostics Ltd. ( (AU:AT1) ) is now available.
Atomo Diagnostics Ltd. announced a change in the director’s interest, confirming the issuance of 1,000,000 unlisted options exercisable at $0.0115, expiring on June 30, 2028, to director Cheri Walker following shareholder approval. This grant highlights the company’s strategy to align leadership incentives with long-term stakeholder value creation.
The most recent analyst rating on (AU:AT1) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Atomo Diagnostics Ltd. stock, see the AU:AT1 Stock Forecast page.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. operates in the medical diagnostics industry, focusing on the development and supply of innovative, user-friendly diagnostic devices and solutions for healthcare markets.
Average Trading Volume: 1,324,935
Technical Sentiment Signal: Buy
Current Market Cap: A$29.98M
See more insights into AT1 stock on TipRanks’ Stock Analysis page.